Study suggests new drug candidate could treat both type 2 diabetes and bone loss

28 Jul 2016


Research, published in EBioMedicine, reports a new diabetes drug that also balances bone deposition and replacement, avoiding the side effect of increased bone fracture common to some diabetes drugs.

EurekAlert


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story